September 20th 2024
Peptides are increasingly used in cosmeceuticals for their ability to enhance cellular communication and functionality in antiaging formulations.
Community Practice Connections™: 19th Annual International Symposium on Melanoma and Other Cutaneous Malignancies®
View More
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
October 16, 2024
Register Now!
Expert Illustrations & Commentaries™: A Deeper Look at the Pathogenesis of Hidradenitis Suppurativa (HS)
View More
Cancer Summaries and Commentaries™: Clinical Updates in Melanoma from Philadelphia
View More
Dermalorian™ Webinar Series on Moderate to Severe Atopic Dermatitis
November 21, 2024 - December 5, 2024
View More
21st Annual International Symposium on Melanoma and Other Cutaneous Malignancies®
February 8, 2025
View More
Expert Illustrations & Commentaries™: Picturing the Potential Role of OX40 and OX40L Inhibitors in Atopic Dermatitis
View More
Hidradenitis Suppurativa (HS): Deepening Foundations of Knowledge in Disease Pathogenesis, Disease Severity Assessment, and Treatment Decision-Making
View More
Clinical Consultations™: Optimizing Treatment Outcomes for Patients with Generalized Pustular Psoriasis
View More
Cases and Conversations™: Applying Practice Techniques to Optimize Diagnosis and Treatment Strategies in Generalized Pustular Psoriasis
View More
Advances in™ Atopic Dermatitis: Addressing Unmet Needs in Patients With Skin of Color
View More
Clinical Consultations™: Guiding Patients with Genital Psoriasis Toward Relief Through a Multidisciplinary Approach
View More
Skin lightening is latest antiperspirant fad
May 1st 2014The newest fad in antiperspirant/deodorants worldwide is skin lightening of the armpits combined with moisture and odor control. The need for armpit skin lightening is most pronounced among the higher Fitzpatrick skin types, in which armpit pigmentation is common.
Clinicians must learn more about science of fillers
May 1st 2014When considering the pluses, minuses and makeup of currently available fillers, according to an expert speaking at Cosmetic Surgery Forum, dermatologists must rely on their own insights and industriousness rather than manufacturers’ messages.
Are U.S. dermatologists missing out on fillers available outside the country?
April 24th 2014It’s no secret - the number of fillers available in the United States doesn’t quite measure up to the products being marketed in other countries. Accessible or not, it’s important for U.S. physicians to keep an eye on what is out of their reach, according to Patrick Trevidic, M.D., in Paris, and Vince Bertucci, M.D., in Toronto.
Core physicians must look ahead, participate, compete
April 1st 2014To maintain a leadership position in aesthetic treatments, core specialists must identify and embrace the game-changing innovations of the future, says an expert. To that end, he recommends participating in drug and device development and clinical trials.
VIDEO: The future of lasers and light-based technology
March 26th 2014We sat down with Florida plastic surgeon Jason Pozner, M.D., FACS, to get his insight about lasers and light-based technology. Pozner will be a panel member in our roundtable discussion about lasers at the 2014 Vegas Cosmetic Surgery and Aesthetic Dermatology meeting in June.
Comprehensive aesthetic consult boosts opportunity for positive outcomes
March 1st 2014Several factors play intertwining roles in achieving a successful aesthetic consult. Actively engaging and connecting with the patient and finding out the patient’s real reasons for wanting to look more youthful are essential for improved aesthetic outcomes, according to an expert.
ATX-101 studies yield favorable findings for reducing submental fat
February 1st 2014Top-line results from North American phase 3 clinical trials show that a series of injections with ATX-101 is safe, well-tolerated, and results in clinically meaningful and statistically significant reductions in submental fat or “double chin.”